Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib.

ABSTRACT:

SUBMITTER: Kristensen LE 

PROVIDER: S-EPMC9909057 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature